GlassScriptPhysician profile
Alfred A Boyd
NPI 1295774339
$4,374.72
in general payments reported to CMS, 2019-2025
41 companies · $1,551 in 2025
The $1,551 reported for 2025 was more than what 93% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $259 · 2020: $140 · 2021: $186 · 2022: $345 · 2023: $896 · 2024: $998 · 2025: $1,551.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,445.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,444.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $544.09 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Dexcom, INC. | $462.30 | 2021-2025 | Dexcom G6 Transmitter |
| Glaxosmithkline, LLC. | $415.08 | 2022-2025 | Shingrix, Trelegy Ellipta, Arexvy |
| Inspire Medical Systems, INC. | $366.12 | 2024-2025 | Inspire |
| Lilly USA, LLC | $336.82 | 2021-2025 | Mounjaro, Jardiance, Trulicity |
| Amgen INC. | $293.60 | 2021-2025 | Repatha, Otezla, Evenity |
| Pfizer INC. | $274.80 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $247.11 | 2019-2025 | Farxiga, Airsupra |
| Abbott Laboratories | $176.16 | 2022-2025 | Freestyle Libre 3 |
| Exact Sciences Corporation | $157.97 | 2023-2025 | Cologuard Collection Kit |
| Astellas Pharma US INC | $127.73 | 2019-2025 | Veozah |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $112.63 | 2023-2025 | Xifaxan, Trulance |
| Boston Scientific Corporation | $79.74 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $59.91 | 2024-2025 | Capvaxive, Gardasil 9, Lagevrio |
| Eisai INC. | $58.82 | 2025 |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alfred Boyd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.